Literature DB >> 20184893

Disulfide-reduced ALS variants of Cu, Zn superoxide dismutase exhibit increased populations of unfolded species.

Can Kayatekin1, Jill A Zitzewitz, C Robert Matthews.   

Abstract

Cu,Zn superoxide dismutase (SOD1) is a dimeric metal-binding enzyme responsible for the dismutation of toxic superoxide to hydrogen peroxide and oxygen in cells. Mutations at dozens of sites in SOD1 induce amyotrophic lateral sclerosis (ALS), a fatal gain-of-function neurodegenerative disease whose molecular basis is unknown. To obtain insights into effects of the mutations on the folded and unfolded populations of immature monomeric forms whose aggregation or self-association may be responsible for ALS, the thermodynamic and kinetic folding properties of a set of disulfide-reduced and disulfide-oxidized Zn-free and Zn-bound stable monomeric SOD1 variants were compared to properties of the wild-type (WT) protein. The most striking effect of the mutations on the monomer stability was observed for the disulfide-reduced metal-free variants. Whereas the WT and S134N monomers are >95% folded at neutral pH and 37 degrees C, A4V, L38V, G93A, and L106V ranged from 50% to approximately 90% unfolded. The reduction of the disulfide bond was also found to reduce the apparent Zn affinity of the WT monomer by 750-fold, into the nanomolar range, where it may be unable to compete for free Zn in the cell. With the exception of the S134N metal-binding variant, the Zn affinity of disulfide-oxidized SOD1 monomers showed little sensitivity to amino acid replacements. These results suggest a model for SOD1 aggregation where the constant synthesis of ALS variants of SOD1 on ribosomes provides a pool of species in which the increased population of the unfolded state may favor aggregation over productive folding to the native dimeric state. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20184893      PMCID: PMC3075925          DOI: 10.1016/j.jmb.2010.02.034

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  48 in total

1.  Multistate equilibrium unfolding of Escherichia coli dihydrofolate reductase: thermodynamic and spectroscopic description of the native, intermediate, and unfolded ensembles.

Authors:  R M Ionescu; V F Smith; J C O'Neill; C R Matthews
Journal:  Biochemistry       Date:  2000-08-08       Impact factor: 3.162

2.  Factors controlling the uptake of yeast copper/zinc superoxide dismutase into mitochondria.

Authors:  Lori Sturtz Field; Yoshiaki Furukawa; Thomas V O'Halloran; Valeria Cizewski Culotta
Journal:  J Biol Chem       Date:  2003-05-14       Impact factor: 5.157

3.  Common denominator of Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis: decreased stability of the apo state.

Authors:  Mikael J Lindberg; Lena Tibell; Mikael Oliveberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

4.  Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis.

Authors:  Lawrence J Hayward; Jorge A Rodriguez; Ji W Kim; Ashutosh Tiwari; Joy J Goto; Diane E Cabelli; Joan Selverstone Valentine; Robert H Brown
Journal:  J Biol Chem       Date:  2002-02-19       Impact factor: 5.157

5.  Familial amyotrophic lateral sclerosis-associated mutations decrease the thermal stability of distinctly metallated species of human copper/zinc superoxide dismutase.

Authors:  Jorge A Rodriguez; Joan S Valentine; Daryl K Eggers; James A Roe; Ashutosh Tiwari; Robert H Brown; Lawrence J Hayward
Journal:  J Biol Chem       Date:  2002-02-19       Impact factor: 5.157

6.  Structure and dynamics of copper-free SOD: The protein before binding copper.

Authors:  Lucia Banci; Ivano Bertini; Francesca Cantini; Mariapina D'Onofrio; Maria Silvia Viezzoli
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

7.  Metal-free ALS variants of dimeric human Cu,Zn-superoxide dismutase have enhanced populations of monomeric species.

Authors:  Anna-Karin E Svensson; Osman Bilsel; Can Kayatekin; Jessica A Adefusika; Jill A Zitzewitz; C Robert Matthews
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

8.  Solution structure of Apo Cu,Zn superoxide dismutase: role of metal ions in protein folding.

Authors:  Lucia Banci; Ivano Bertini; Fiorenza Cramaro; Rebecca Del Conte; Maria Silvia Viezzoli
Journal:  Biochemistry       Date:  2003-08-19       Impact factor: 3.162

9.  The structure of holo and metal-deficient wild-type human Cu, Zn superoxide dismutase and its relevance to familial amyotrophic lateral sclerosis.

Authors:  Richard W Strange; Svetlana Antonyuk; Michael A Hough; Peter A Doucette; Jorge A Rodriguez; P John Hart; Lawrence J Hayward; Joan S Valentine; S Samar Hasnain
Journal:  J Mol Biol       Date:  2003-05-09       Impact factor: 5.469

10.  Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS.

Authors:  Jennifer Stine Elam; Alexander B Taylor; Richard Strange; Svetlana Antonyuk; Peter A Doucette; Jorge A Rodriguez; S Samar Hasnain; Lawrence J Hayward; Joan Selverstone Valentine; Todd O Yeates; P John Hart
Journal:  Nat Struct Biol       Date:  2003-06
View more
  25 in total

1.  Incorporation of a Reporter Peptide in FPOP Compensates for Adventitious Scavengers and Permits Time-Dependent Measurements.

Authors:  Ben Niu; Brian C Mackness; Don L Rempel; Hao Zhang; Weidong Cui; C Robert Matthews; Jill A Zitzewitz; Michael L Gross
Journal:  J Am Soc Mass Spectrom       Date:  2016-12-06       Impact factor: 3.109

Review 2.  Superoxide dismutases and superoxide reductases.

Authors:  Yuewei Sheng; Isabel A Abreu; Diane E Cabelli; Michael J Maroney; Anne-Frances Miller; Miguel Teixeira; Joan Selverstone Valentine
Journal:  Chem Rev       Date:  2014-04-01       Impact factor: 60.622

3.  Local unfolding of Cu, Zn superoxide dismutase monomer determines the morphology of fibrillar aggregates.

Authors:  Feng Ding; Yoshiaki Furukawa; Nobuyuki Nukina; Nikolay V Dokholyan
Journal:  J Mol Biol       Date:  2011-12-21       Impact factor: 5.469

4.  Cutting off functional loops from homodimeric enzyme superoxide dismutase 1 (SOD1) leaves monomeric β-barrels.

Authors:  Jens Danielsson; Martin Kurnik; Lisa Lang; Mikael Oliveberg
Journal:  J Biol Chem       Date:  2011-06-23       Impact factor: 5.157

5.  The H2A-H2B dimeric kinetic intermediate is stabilized by widespread hydrophobic burial with few fully native interactions.

Authors:  Paul J Guyett; Lisa M Gloss
Journal:  J Mol Biol       Date:  2011-11-23       Impact factor: 5.469

6.  Nonnative structure in a peptide model of the unfolded state of superoxide dismutase 1 (SOD1): Implications for ALS-linked aggregation.

Authors:  Noah R Cohen; Jill A Zitzewitz; Osman Bilsel; C Robert Matthews
Journal:  J Biol Chem       Date:  2019-07-24       Impact factor: 5.157

7.  Conformational Disorder of the Most Immature Cu, Zn-Superoxide Dismutase Leading to Amyotrophic Lateral Sclerosis.

Authors:  Yoshiaki Furukawa; Itsuki Anzai; Shuji Akiyama; Mizue Imai; Fatima Joy C Cruz; Tomohide Saio; Kenichi Nagasawa; Takao Nomura; Koichiro Ishimori
Journal:  J Biol Chem       Date:  2015-12-22       Impact factor: 5.157

8.  Enthalpic barriers dominate the folding and unfolding of the human Cu, Zn superoxide dismutase monomer.

Authors:  Can Kayatekin; Noah R Cohen; C Robert Matthews
Journal:  J Mol Biol       Date:  2012-09-18       Impact factor: 5.469

9.  Altered thiol chemistry in human amyotrophic lateral sclerosis-linked mutants of superoxide dismutase 1.

Authors:  Carles Solsona; Thomas B Kahn; Carmen L Badilla; Cristina Álvarez-Zaldiernas; Juan Blasi; Julio M Fernandez; Jorge Alegre-Cebollada
Journal:  J Biol Chem       Date:  2014-08-04       Impact factor: 5.157

10.  Metal-free ALS variants of dimeric human Cu,Zn-superoxide dismutase have enhanced populations of monomeric species.

Authors:  Anna-Karin E Svensson; Osman Bilsel; Can Kayatekin; Jessica A Adefusika; Jill A Zitzewitz; C Robert Matthews
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.